PMID: 1195139Dec 1, 1975Paper

Effect of ouabain and its interaction with diphenylhydantoin on cardiac arrhythmias induced by hypothalamic stimulation

The Journal of Pharmacology and Experimental Therapeutics
D E Evans, R A Gillis

Abstract

Cardiac arrhythmias induced by central nervous system stimulation in the cat were used to evaluate the possible central nervous system effects of ouabain and diphenylhydantoin. Electrical stimulation of the posterior portion of the hypothalamus resulted in alterations of cardiac rhythm, and recordings from cardiac-bound sympathetic nerves revealed continuous activity during the time of arrhythmia. Intravenous administration of small doses of ouabain (i.e., 10-30 mug/kg) prevented both the arrhythmias and the associated hyperactivity on the sympathetic nerves. The antiarrhythmic effect was not present in animals with denervated baroreceptors indicating that the ouabain effects were due to sensitization of baroreceptor reflexes. Intravenous administration of large but subarrhythmic doses of ouabain (i.e., 60-80 mug/kg) converted a subarrhythmogenic hypothalamic electrical stimulus to a threshold stimulus for arrhythmias. The increased response of the heart to brain stimulation in the presence of these doses of ouabain was associated with an increased discharge of cardiac sympathetic nerves, indicating that ouabain was exerting its arrhythmogenic enhancing effect on the central nervous system rather than on the heart. Pretreatment...Continue Reading

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

The Journal of Pharmacology and Experimental Therapeutics
D G Pace, R A Gillis
The Journal of Pharmacology and Experimental Therapeutics
L C WeaverT M Brody
Archives Internationales De Pharmacodynamie Et De Thérapie
C Y ChaiS C Wang
© 2022 Meta ULC. All rights reserved